GNPTAB-related mucolipidosis (ML II I-cell disease and ML III alpha/beta)
Autosomal recessive
Faulty tagging of lysosomal enzymes causes severe infantile coarse features, skeletal dysplasia and heart disease (ML II), or a milder later-onset form with joint stiffness and skeletal changes (ML III).
What a diagnosis changes
Care is supportive, with orthopaedic, cardiac and airway monitoring.
Genes analysed
Also known as
GNPTAB-related disorder; UDP-N-acetylglucosamine-1-phosphotransferase subunit alpha/beta deficiency
Includes 2 related subtypes ↓Hide subtypes ↑
- mucolipidosis type II
- mucolipidosis type III, alpha/beta
